APA
Stewart A. K., Vescio R., Schiller G., Ballester O., Noga S., Rugo H., Freytes C., Stadtmauer E., Tarantolo S., Sahebi F., Stiff P., Meharchard J., Schlossman R., Brown R., Tully H., Benyunes M., Jacobs C., Berenson R., White M., DiPersio J., Anderson K. C. & Berenson J. (20010920). Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Stewart A K, Vescio R, Schiller G, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, White M, DiPersio J, Anderson K C and Berenson J. 20010920. Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Stewart A. K., Vescio R., Schiller G., Ballester O., Noga S., Rugo H., Freytes C., Stadtmauer E., Tarantolo S., Sahebi F., Stiff P., Meharchard J., Schlossman R., Brown R., Tully H., Benyunes M., Jacobs C., Berenson R., White M., DiPersio J., Anderson K. C. and Berenson J. (20010920). Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Stewart A K, Vescio R, Schiller G, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, White M, DiPersio J, Anderson K C and Berenson J. Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20010920.